ABSTRACT: Nanotechnology has offered enormous improvement in field of therapeutics by means of designing of nano-carriers that can cross biological barriers and are able to target cellular reservoirs. The aim of the present investigation was to formulate and evaluate Niosomes, a synthetic microscopic non-ionic surfactant vesicles formed on the admixture of a non-ionic surfactant, cholesterol and phosphate with subsequent hydration in aqueous media. The delivery of drugs by "vesicular drug delivery system" such as niosomes provides several important advantages over conventional drug therapy. Ofloxacin was selected as a suitable drug for the present study because it is a potent secondgeneration fluoroquinolone active against a broad range of gram positive and gram-negative aerobic and anaerobic bacteria. In the present investigation three formulations of Niosomal drug delivery system of ofloxacin with non ionic surfactant, span 60, in various proportions were prepared and evaluated for Morphological characterization, Encapsulation efficiency, In-vitro drug release study. The Ofloxacin niosomes were prepared by lipid film hydration method. The prepared ofloxacin niosomes showed a vesicle size of 100-300 nm, the entrapment efficiency was 78.4%. The partition coefficient value of ofloxacin was found to be 0.5.
INTRODUCTION
Niosomes are microscopic lamellar structures, which are formed on the admixture of non-ionic surfactant of the alkyl or dialkyl polyglycerol ether class and cholesterol with subsequent hydration in aqueous media. Structurally, niosomes are similar to liposomes, in that they are also made up of a bilayer. However, the bilayer in the case of niosomes is made up of non-ionic surface active agents rather than phospholipids as seen in case of liposomes. A typical noisome vesicle would consist of a vesicle forming ampiphilie i.e. a non-ionic surfactant such as Span-60, which is usually stabilized by the addition of cholesterol and a small amount of anionic surfactant such as diacetyl phosphate, which helps in stabilizing the vesicle. Ofloxacin is the fluoroquinolnes are important antimicrobial agents that have demonstrated activity against a wide range of Gram-positive and Gram-negative organisms and have proved useful against micro-organisms that are resistant to other antibacterial agents.
Melting Point: Ofloxacin melts at 270 degree C to 273 degree C [1] Solubility: Ofloxacin is freely soluble in PBS and acetic acid, slightly soluble in water, methanol, ethanol or acetone.
The octanol/water partition coefficient for ofloxacin was reported to be -0.48 by [2] Appearance: Ofloxacin occurs as a pale yellow or bright yellow crystalline powder, and with a bitter taste [3] Storage: Ofloxacin should be stored at 40ºc in the dark to minimise photolytically induced degradation [4] Pharmacology: Ofloxacin is a quinolone antibiotic. Ofloxacin is bacterial and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase, which allows the untwisting required to replicate one DNA double helix into two. Mechanism of Action: Ofloxacin acts on DNA gyrase, an enzyme which, like human topoisomerase, prevents the excessive supercoiling of DNA during replication or transcription.
II. RELATED WORK
Niosomes are biodegradable, biocompatible, nontoxic and capable of encapsulating large quantities of material in relatively smaller volumes of vesicles [5] Drug delivery systems using colloidal particulate carriers such as liposomes or niosomes have distinct advantages over conventional dosage forms because the particles can act as drug containing reservoirs, and modification of the particle composition or surface can adjust the drug release rate and the affinity for the target site [6] Proniosomes, hydrated by agitation in hot water for a short period of time, offer a versatile vesicle delivery concept with the potential for drug delivery via the transdermal route [7] Temperature change of niosomal system affects assembly of surfactants into vesicles and also induces vesicle shape transformations [10] Niosomes prepared from span 60 exhibits highest protection of insulin against proteolytic enzymes and good stability in presence of sodium deoxycholate and storage temperature. Ofloxacin is freely soluble in acetic acid, slightly soluble in water, methanol, ethanol or acetone. The octanol/water partition coefficient for ofloxacin was reported to be -0.48 [1, 2] Ofloxacin which is the focus of this review is a second generation fluoroquinolone with a 6-fluoro substituent and a 7-piperazinyl substituent on the quinolone ring structure [11] Entrapped niosomes were prepared by hand shaking and ether injection process with different ratios of (1:1, 1:2 and 1:3) cholesterol and Span-80 (Non-ionic surfactant). The niosomes prepared were in the size of 0.5-2.5 microns in case of hand shaking process and 0.5-2.5 microns in case of Ether injection process.
The release of drug from niosomes is determined using the membrane diffusion technique. Suspend an accurately measured amount of drug niosomal formulation in 1ml phosphate buffer saline and transferred to a glass tube covered at its lower end by a soaked cellulose membrane [12] Drug delivery particle, an "immunoniosome" has been successfully synthesized and demonstrated the use of particle to target a specific site important in the inflammatory process, both in static cell culture and under flow 
III. MATERIALS AND METHODS

MATERIALS REQUIRED
METHODOLOGY Quantitative Estimation of Ofloxacin:
Spectrophotometric method was done as reported [5] . Ofloxacin was prepared in PBS in concentration range of 10 mg in 100 ml. Different aliquots in gradation of 0.2, 0.4........2 ml volume were taken in each test tube and the final volume was made to 10 ml with PBS. The absorbance was taken at 287 nm and standard plot were prepared by Shimadzu 1800 U.V. Visible Spectrophotometer.
Preformulation Study: Preformulation study is the prime requisite which is required to be done before using any drug for the preparation of dosage form. Before the preparation of noisome the following preformulation studies were done for ofloxacin.
1. Physical Appearance: Ofloxacin sample which was obtained from Zydus Cadila Ahmedabad was minutely observed for the physical appearance. The drug used was whitish yellow, amorphous and odourless powder.
Melting Point:
Ofloxacin study was conducted to test melting point and it was found that ofloxacin melt within the range of 270ºC -273ºC. 3. Solubility Profile: Solubility is defined as spontaneous interaction of two or more substances to form a homogeneous molecular dispersion. 
Partition Coefficient:
Partition coefficient is defined as the ratio of unionized drug distributed between organic and aqueous phase at equilibrium. C oil P o/w = ----------C water The partition coefficient of ofloxacin was determined in n-octanol : PBS and was found to be 0.5. 
Preparation of Niosomes:
In the present study the noisome were prepared using ether injection method and hand shaking method (Thin Film Hydration) and the comparative study were done between noisome prepared by above two methods.
Ether Injection Method:
10 ml of Diethyl Ether was taken in 100 ml beaker. To it surfactant-cholesterol mixture was added in appropriate ratio. This solution was filled in a 20 ml syringe of 40 guage. In a 250 ml beaker 10 ml PBS was taken. To it 200 mg of Ofloxacin was added. The beaker was kept in magnetic stirrer in heating condition. The contents of the syringe were injected drop wise into a mixture. The procedure was repeated six times with various samples A1, A2, A3, B1, B2 and B3.
Hand Shaking Method (Film Hydration):
The mixture of vesicle forming ingredients ie. Surfactant and Cholesterol was dissolved in a volatile organic solvent. 10 ml Diethyl Ether was taken in a round bottom flask. The organic solvent was removed at room temperature (37ºc) using Rotary Vacuum Evaporator-Buchi type leaving a thin layer of solid mixture. The dried film of surfactant and cholesterol was rehydrated with 200 mg of Ofloxacin contained in 1ml of PBS with gentle agitation. The niosomes were carefully removed and kept aside for further analysis.
Evaluation of Niosomes:  Determination of Vesicle Shape and Size by Microscopy:
For determining the vesicle shape and size freshly prepared samples of noisome were examined under Olympus optical microscope. The size of the noisome was measured by using precalibrated micrometer. The least count of ocular micrometer was calculated as 1.53 µm and around 10 particles were analyzed in each of the samples. 
Determination of Vesicle
 Determination of Entrapent Efficiency:
The niosomal preparations which were prepared using different concentration of cholesterol and surfactants were taken. All of the preparations were centrifuged in REMI table top centrifuge to separate the niosomal vesicle as a pellet. The supernatant was collected and analyzed for ofloxacin content. The amount of drug un entrapped was calculated which finally gave the % entrapment efficiency.
Amount of Ofloxacin Entrapped Entrapment Efficiency = --------------------------------------X 100
Total It was found that values for A2 formula were significantly more from other respective formulations. It was observed from above mentioned results that formula A2 had highest zone of inhibition.Hence, it may be concluded that formulation A2 exhibited better antimicrobial activity in comparison to respective formulation.
IV. RESULTS AND DISCUSSION
In the first step, Ofloxacin niosomes were prepared by lipid film hydration method in which mixture of surfactant, cholesterol and drug was taken and dissolved in organic solvents. The organic solvents were removed by rotary evaporation method, so as to form a thin film of components on the wall of the rotating flask. The film was hydrated with 8-10 ml of PBS for 45 min at room temperature with gentle shaking the niosomal suspension was further hydrated for 24 hrs. Niosomes were also prepared by Ether Injection method. 
